IL4R and gallbladder carcinoma: The Cy-IL4Rα-positivity predicted a 1.895-fold (95% CI; 1.092–3.288) greater risk of death and a 2.048-fold (95% CI; 1.183–3.548) greater risk of relapse or death of gallbladder carcinoma patients (Table 2).